Poly(ester amide) Co-polymers Promote Blood and Tissue Compatibility
- 1 January 2009
- journal article
- Published by Taylor & Francis Ltd in Journal of Biomaterials Science, Polymer Edition
- Vol. 20 (11), 1495-1511
- https://doi.org/10.1163/092050609x12464344572881
Abstract
A family of biodegradable poly(ester amide) (PEA) co-polymers based on naturally occurring α-amino acids has been developed for applications ranging from biomedical device coatings to delivery of therapeutic biologics. An important feature of PEA co-polymer coatings may be their ability to promote a natural healing response. To gain insight into this process, representative elastomeric PEAs designed for a cardiovascular stent coating were compared to non-degradable and biodegradable polymers in a series of in vitro assays to examine blood and cellular responses. Each PEA contained L-leucine and L-lysine with the latter derivatized by either benzyl alcohol or the nitroxide radical 4-amino TEMPO as a pendant group. Monocytes adherent to PEA secreted reduced levels of the pro-inflammatory interleukins (IL)-6 and IL-1β into the culture supernatant compared to those on comparison polymers but secreted significantly higher amounts of the anti-inflammatory mediator, IL-1 receptor antagonist. As a measure of pro-healing tissue compatibility for cardiovascular applications, endothelial cells adhered, spread, and proliferated on PEA. PEA was also determined to be non-hemolytic and did not deplete platelets or leukocytes from whole blood. ATP release from freshly isolated human platelets on PEA, a measure of their activation, was comparable to the well-known and compatible comparison polymers poly(lactic-co-glycolic acid) and n-poly(butyl methacrylate). Taken together, these in vitro studies of the blood and tissue compatibility of these biodegradable, α-amino-acid-based PEAs suggest that they may support a more natural healing response by attenuating the pro-inflammatory reaction to the implant and promoting growth of appropriate cells for repair of the tissue architecture.Keywords
This publication has 22 references indexed in Scilit:
- From Drug-Eluting Stents to Biopharmaceuticals: Poly(ester amide) a Versatile New Bioabsorbable BiopolymerPublished by American Chemical Society (ACS) ,2008
- Stent?based tempamine delivery on neointimal formation in a porcine coronary modelAcute Cardiac Care, 2006
- In vitro enzymatic biodegradation of amino acid based poly(ester amide)s biomaterialsJournal of Materials Science: Materials in Medicine, 2004
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseThe New England Journal of Medicine, 2004
- Biodegradation of amino-acid-based poly(ester amide)s: in vitro weight loss and preliminary in vivo studiesJournal of Biomaterials Science, Polymer Edition, 2004
- In-vivo biocompatibility evaluation of stents coated with a new biodegradable elastomeric and functional polymerCoronary Artery Disease, 2002
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Rapid purification of human peripheral blood monocytes by centrifugation through Ficoll-Hypaque and Sepracell-MNJournal of Immunological Methods, 1988
- Inflammatory Response to ImplantsASAIO Journal, 1988
- Biology of interleukin 1The FASEB Journal, 1988